s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
4
Polinsky David: Statement of changes in beneficial ownership of securities
Filed
Tuesday, September 1, 2026
Period
Aug 31, 2026
Accession number
0001493152-26-041133
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header